Kathrin R. Sidell, Ph.D. - Publications

Vanderbilt University, Nashville, TN 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2003 Sidell KR, Montine KS, Picklo MJ, Olsen SJ, Amarnath V, Montine TJ. Mercapturate metabolism of 4-hydroxy-2-nonenal in rat and human cerebrum. Journal of Neuropathology and Experimental Neurology. 62: 146-53. PMID 12578224  0.84
2002 Montine KS, Sidell KR, Zhang J, Montine TJ. Dopamine thioethers: formation in brain and neurotoxicity. Neurotoxicity Research. 4: 663-669. PMID 12709304 DOI: 10.1080/1029842021000045435  0.84
2001 Sidell KR, Amamath V, Montine TJ. Dopamine thioethers in neurodegeneration. Current Topics in Medicinal Chemistry. 1: 519-27. PMID 11895128  0.84
2001 Sidell KR, Olson SJ, Ou JJ, Zhang Y, Amarnath V, Montine TJ. Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivo. Journal of Neurochemistry. 79: 510-21. PMID 11701754 DOI: 10.1046/j.1471-4159.2001.00586.x  0.84
2000 Montine TJ, Amarnath V, Picklo MJ, Sidell KR, Zhang J, Graham DG. Dopamine mercapturate can augment dopaminergic neurodegeneration. Drug Metabolism Reviews. 32: 363-76. PMID 11139134 DOI: 10.1081/DMR-100102339  0.84
1999 Bassett CN, Neely MD, Sidell KR, Markesbery WR, Swift LL, Montine TJ. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo. Lipids. 34: 1273-80. PMID 10652986  0.84
1999 Valyi-Nagy T, Sidell KR, Marnett LJ, Roberts LJ, Dermody TS, Morrow JD, Montine TJ. Divergence of brain prostaglandin H synthase activity and oxidative damage in mice with encephalitis. Journal of Neuropathology and Experimental Neurology. 58: 1269-75. PMID 10604752  0.84
1999 Montine TJ, Sidell KR, Crews BC, Markesbery WR, Marnett LJ, Roberts LJ, Morrow JD. Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology. 53: 1495-8. PMID 10534257  0.84
1999 Neely MD, Sidell KR, Graham DG, Montine TJ. The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. Journal of Neurochemistry. 72: 2323-33. PMID 10349841 DOI: 10.1046/j.1471-4159.1999.0722323.x  0.84
1998 Montine KS, Reich E, Neely MD, Sidell KR, Olson SJ, Markesbery WR, Montine TJ. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. Journal of Neuropathology and Experimental Neurology. 57: 415-25. PMID 9596412  0.84
Show low-probability matches.